Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer

Despite great advances in our understanding of the pathobiology of colorectal cancer and the genetic and environmental factors that mitigate its onset and progression, a paucity of effective treatments persists. The five-year survival for advanced, stage IV disease remains substantially less than 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Osman, Tolaymat, Mazen, Hu, Shien, Xie, Guofeng, Raufman, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828259/
https://www.ncbi.nlm.nih.gov/pubmed/33450835
http://dx.doi.org/10.3390/ijms22020716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828259/
https://www.ncbi.nlm.nih.gov/pubmed/33450835
http://dx.doi.org/10.3390/ijms22020716

Ejemplares similares